Mechanical and Electrical Dyssynchrony During His-Bundle Pacing Versus His-Bundle Area Right Ventricular Pacing
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of this study is to evaluate mechanical and electrical cardiac dyssynchrony in patients with pacemakers and the right ventricular electrode implanted in His Bundle area.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 14, 2020
CompletedStudy Start
First participant enrolled
December 14, 2020
CompletedFirst Posted
Study publicly available on registry
January 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedNovember 3, 2022
November 1, 2022
1.9 years
December 14, 2020
November 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Interventricular mechanical delay
InterVentricular Mechanical Dyssynchrony Parameter 1
Mid-term: 3-6 months after pacemaker implantation
Interventricular mechanical delay
InterVentricular Mechanical Dyssynchrony Parameter 1
Long term: 12-15 months after pacemaker implantation
Free-wall-LV-to-RV-delay
InterVentricular Mechanical Dyssynchrony Parameter 2
Mid-term: 3-6 months after pacemaker implantation
Free-wall-LV-to-RV-delay
InterVentricular Mechanical Dyssynchrony Parameter 2
Long term: 12-15 months after pacemaker implantation
Septal-to-posterior wall motion delay
IntraVentricular Mechanical Dyssynchrony Parameter 1
Mid-term: 3-6 months after pacemaker implantation
Septal-to-posterior wall motion delay
IntraVentricular Mechanical Dyssynchrony Parameter 1
Long term: 12-15 months after pacemaker implantation
Opposing wall motion delay
IntraVentricular Mechanical Dyssynchrony Parameter 2
Long term: 12-15 months after pacemaker implantation
Opposing wall motion delay
IntraVentricular Mechanical Dyssynchrony Parameter 2
Mid-term: 3-6 months after pacemaker implantation
systolic dyssynchrony index
Ventricular Mechanical Dyssynchrony Parameter 1
Long term: 12-15 months after pacemaker implantation
systolic dyssynchrony index
Ventricular Mechanical Dyssynchrony Parameter 1
Mid-term: 3-6 months after pacemaker implantation
QRS duration
Electrical dyssynchrony Parameter
Mid-term: 3-6 months after pacemaker implantation
QRS duration
Electrical dyssynchrony Parameter
Long term: 12-15 months after pacemaker implantation
Secondary Outcomes (10)
Radial strain
Mid-term: 3-6 months after pacemaker implantation
Radial strain
Long term: 12-15 months after pacemaker implantation
Left Ventricular Ejection Fraction
Mid-term: 3-6 months after pacemaker implantation
Left Ventricular Ejection Fraction
Long term: 12-15 months after pacemaker implantation
Global longitudinal strain
Mid-term: 3-6 months after pacemaker implantation
- +5 more secondary outcomes
Interventions
Intervention includes (1) pacemaker reprogramming (2) echocardiographic parameters acquisition (3) ECG recording
Eligibility Criteria
Patients with bradyarrhythmia and indications for de novo permanent pacemaker implantation. The decision for pacing lead placement in His Bundle is left for physician discretion. Patients after pacemaker system implantation with His Bundle successfully pacing are to be asked to participate in the study. After having written informed consent obtained patients are to be scheduled for ventricular synchrony evaluation with ECHO and ECG after 3-6 months after implant (mid-term) and after 12 months (long-term).
You may qualify if:
- all adult patients after implantation of pacemaker system with pacing lead successfully captured His Bundle (selectively or/and nonselectively)
You may not qualify if:
- not willing or incapable to give written informed consent;
- previous implanted cardiac electronic device (pacemaker, implantable cardioverter-defibrillator, cardiac resynchronization therapy device)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Electrocardiology Medical University of Lodz
Lodz, 93-216, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 14, 2020
First Posted
January 6, 2021
Study Start
December 14, 2020
Primary Completion
October 30, 2022
Study Completion
December 31, 2022
Last Updated
November 3, 2022
Record last verified: 2022-11